Brought to you by the International Journal of Pharmaceutical Compounding FREE TRIAL    FORMULATIONS    MY ACCOUNT 
Compounding This Week Newsletter from www.CompoundingToday.com
Our Compounding Knowledge, Your Peace of Mind
September 15, 2017  |  Volume 14  |  Issue 37
IN THIS ISSUE
 
SUBSCRIPTIONS / INFO
 
CLASSIFIEDS
 
ABOUT COMPOUNDINGTODAY
 
FREE RESOURCES
 
SUBSCRIBER RESOURCES
Serving Compounding Pharmacy Facilities with supplies for compounding equipment & facility preparation. Disinfectants, cleaners, garments, gloves, etc. www.yourcleanroomsupplier.com
30% Off API's at Total Pharmacy Supply with Promo Code API20! Visit www.totalpharmacysupply.com or call 800-878-2822
 
Loyd V. Allen, Jr., Ph.d., R.Ph Letter from the Editor
The Biopharmaceutics Classification System (BCS) and Compounding: Part 10

Continuing our BCS topic, this week we will look at a summary of the BCS and the BDDCS. Recall that the BCS is developed based on solubility and permeability, and the BDDCS is based on solubility and metabolism. They can be placed in a table such as the following:

Class 1High SolubilityHigh PermeabilityExtensive Metabolism
Class 2Low SolubilityHigh PermeabilityExtensive Metabolism
Class 3High SolubilityLow PermeabilityPoor Metabolism
Class 4Low SolubilityLow PermeabilityPoor Metabolism

Note: The information in column 2 applies to both BCS and BDDCS. The information in column 3 (red) applies to BCS, and the information in column 4 (green) applies to BDDCS.

BCS: Dissolution and GI permeability are the fundamental parameters controlling the rate and extension of drug absorption.

BDDCS: Includes the effect of food, absorptive transporters, efflux transporters, and routes of elimination (renal/biliary) on overall drug absorption and bioavailability for immediate-release oral dosage forms, which is more than just the permeability.

Next week: New drug development, regulatory drug approval, and "biowaivers."


Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition

 

News

Mohawk Tribe to Protect Allergan Restasis Patent for $Millions!
Allergan will transfer the rights to Restasis to the Saint Regis Mohawk Tribe in an unusual deal to protect it from patent challenges. Indian tribes have sovereign immunity from such challenges, and they will receive a one-time payment of $13.75 million and annual royalties of around $15 million. Sales of Restasis, which totaled over $1.5 billion last year, account for about 15% of Allergan's profits.


If successful, there will probably be multiple branded (drug) companies housing their patents with Indian tribes; possibly the next big Indian tribe industry after gaming. The Saint Regis Mohawk Tribe operates casinos in upstate New York.
http://www.reuters.com/article/us-allergan-patents-mohawk/allergan-pays-mohawk-tribe-to-protect-patents-from-challenges-idUSKCN1BJ2DK

 

IJPC Now on Facebook and Youtube

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information - http://www.facebook.com/IJPCompounding

Learn about the Journal's new multi-media features and view our growing collection of educational and training videos at www.ijpc.com/video or by subscribing to our Youtube channel at https://www.youtube.com/user/IJPCompounding.

 

Did You Know ...

� that from the seat of a tractor:

  • Forgive your enemies; it messes up their heads?
  • Don't interfere with somethin' that ain't botherin' you none?
  • Live simply, love generously, care deeply, speak kindly, and leave the rest to God?
 

Tip of the Week

Make the lie big!
Make it simple!
Keep saying it!
Eventually they will believe it!
    ï¿½Adolph Hitler

 

Looking Back

Jar so big,
Cost so small,
Coolest, smoothest,
Shave of all!
     Burma Shave

Copyright 2017
International Journal of Pharmaceutical Compounding, Inc.
122 N Bryant Ave, Edmond OK 73034
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
info@compoundingtoday.com
Reprints & Permissions: Reprints@ijpc.com